198 related articles for article (PubMed ID: 10553164)
1. Impact of immunophenotyping on management of acute leukemias.
Béné MC; Bernier M; Castoldi G; Faure GC; Knapp W; Ludwig WD; Matutes E; Orfao A; van't Veer M
Haematologica; 1999 Nov; 84(11):1024-34. PubMed ID: 10553164
[TBL] [Abstract][Full Text] [Related]
2. New methodologic approaches for immunophenotyping acute leukemias.
Basso G; Buldini B; De Zen L; Orfao A
Haematologica; 2001 Jul; 86(7):675-92. PubMed ID: 11454522
[TBL] [Abstract][Full Text] [Related]
3. [Detection of minimal residual disease in acute leukemias by flow cytometry].
Scolnik MP
Medicina (B Aires); 2000; 60 Suppl 2():83-6. PubMed ID: 11188938
[TBL] [Abstract][Full Text] [Related]
4. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and classification of the acute leukemias: recent advances and controversial issues.
Taylor CG; Stasi R; Bastianelli C; Venditti A; Del Poeta G; Amadori S; Sargent J
Hematopathol Mol Hematol; 1996; 10(1-2):1-38. PubMed ID: 8792146
[TBL] [Abstract][Full Text] [Related]
6. Leukemias of indeterminant lineage.
Lee EJ; Schiffer CA
Clin Lab Med; 1990 Dec; 10(4):737-54. PubMed ID: 2272172
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody panels for acute leukemia and myelodysplastic syndrome diagnosis. Results of a co-operative quality control group.
Basso G; Bernasconi P; Chianese R; Crovetti G; Garbaccio G; Iavarone A; Pautasso M; Santagostino A; Stacchini A;
J Biol Regul Homeost Agents; 2001; 15(2):145-55. PubMed ID: 11501972
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotyping of acute leukaemias.
Béné MC
Immunol Lett; 2005 Apr; 98(1):9-21. PubMed ID: 15790504
[TBL] [Abstract][Full Text] [Related]
9. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
Pálóczi K; Nahajevszky S; Jakab K; Regéczy N; Gopcsa L; László E; Földi J
Orv Hetil; 2000 Nov; 141(46):2487-92. PubMed ID: 11126681
[TBL] [Abstract][Full Text] [Related]
10. [Monoclonal antibodies in diagnosis of acute leukemias].
Krawczyńska A; Robak T
Przegl Lek; 1996; 53(1):20-5. PubMed ID: 8711170
[TBL] [Abstract][Full Text] [Related]
11. [Morphological, immunological and cytogenetic diagnosis in acute leukemias].
Ratei R; Sperling C; Ludwig WD
Ther Umsch; 1996 Feb; 53(2):88-96. PubMed ID: 8629269
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
14. [Cytomorphology of acute mixed leukemia].
Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
[TBL] [Abstract][Full Text] [Related]
15. [Multi-parametric analysis for leukemic immunophenotyping].
Ujiie M; Sonoda A; Todoroki T; Amano H; Uchida T; Kawai Y; Watanabe K
Rinsho Byori; 1998 Nov; 46(11):1163-7. PubMed ID: 9868303
[TBL] [Abstract][Full Text] [Related]
16. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination.
Thalhammer-Scherrer R; Mitterbauer G; Simonitsch I; Jaeger U; Lechner K; Schneider B; Fonatsch C; Schwarzinger I
Am J Clin Pathol; 2002 Mar; 117(3):380-9. PubMed ID: 11888077
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic diagnosis of acute leukemia by using decision tree induction.
Cualing H; Kothari R; Balachander T
Lab Invest; 1999 Feb; 79(2):205-12. PubMed ID: 10068208
[TBL] [Abstract][Full Text] [Related]
18. Immunological evaluation of minimal residual disease (MRD) in acute myeloid leukaemia (AML).
San-Miguel JF; Vidriales MB; Orfão A
Best Pract Res Clin Haematol; 2002 Mar; 15(1):105-18. PubMed ID: 11987919
[TBL] [Abstract][Full Text] [Related]
19. [Contribution of immunotyping in the diagnosis and in the prognosis of acute leukemia].
Merle-Béral H; Boucheix C
Rev Prat; 1996 Jan; 46(1):30-6. PubMed ID: 8596888
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
DiGiuseppe JA; Fuller SG; Borowitz MJ
Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
